Medtronic plc Files 8-K on Shareholder Votes and Debt

Ticker: MDT · Form: 8-K · Filed: 2024-10-21T00:00:00.000Z

Sentiment: neutral

Topics: debt, corporate-governance

TL;DR

Medtronic filed an 8-K detailing shareholder votes and various senior notes due between 2025 and 2031.

AI Summary

On October 17, 2024, Medtronic plc filed an 8-K to report the submission of matters to a vote of security holders and financial statements. The filing also details various senior notes due in the coming years, including notes due 2025, 2027, 2028, 2029, and 2031, with varying interest rates.

Why It Matters

This filing provides transparency regarding Medtronic's corporate governance actions and its outstanding debt obligations, which are key factors for investors assessing financial health and management.

Risk Assessment

Risk Level: low — This is a routine filing reporting on shareholder votes and debt, not indicating any immediate operational or financial distress.

Key Numbers

Key Players & Entities

FAQ

What specific matters were submitted to a vote of security holders?

The filing indicates 'Submission of Matters to a Vote of Security Holders' as an item, but the specific details of these matters are not provided in the excerpt.

What are the interest rates on the senior notes due in 2025?

The filing lists senior notes due in 2025 with interest rates of 0.250%, 0.000%, and 2.625%.

What is the maturity date for the senior notes with a 3.650% interest rate?

The senior notes with a 3.650% interest rate are due in 2029.

Does the filing mention any new debt issuance?

The filing primarily lists existing senior notes with various maturity dates and interest rates, and does not explicitly mention new debt issuance in the provided excerpt.

What is the filing date of this 8-K?

This 8-K was filed on October 21, 2024.

From the Filing

0001613103-24-000151.txt : 20241021 0001613103-24-000151.hdr.sgml : 20241021 20241021162145 ACCESSION NUMBER: 0001613103-24-000151 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20241017 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20241021 DATE AS OF CHANGE: 20241021 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Medtronic plc CENTRAL INDEX KEY: 0001613103 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 000000000 FISCAL YEAR END: 0425 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36820 FILM NUMBER: 241383741 BUSINESS ADDRESS: STREET 1: BUILDING TWO PARKMORE BUSINESS PARK WEST CITY: GALWAY STATE: L2 ZIP: 1 BUSINESS PHONE: 01135314381700 MAIL ADDRESS: STREET 1: BUILDING TWO PARKMORE BUSINESS PARK WEST CITY: GALWAY STATE: L2 ZIP: 1 FORMER COMPANY: FORMER CONFORMED NAME: Medtronic Ltd DATE OF NAME CHANGE: 20150112 FORMER COMPANY: FORMER CONFORMED NAME: Medtronic Holdings Ltd DATE OF NAME CHANGE: 20140711 FORMER COMPANY: FORMER CONFORMED NAME: Kalani I Ltd DATE OF NAME CHANGE: 20140709 8-K 1 mdt-20241017.htm 8-K mdt-20241017 0001613103 H91 VY19 false 0001613103 2024-10-17 2024-10-17 0001613103 us-gaap:CommonStockMember 2024-10-17 2024-10-17 0001613103 mdt:A0.250SeniorNotesDue2025Member 2024-10-17 2024-10-17 0001613103 mdt:A0.000SeniorNotesDue2025Member 2024-10-17 2024-10-17 0001613103 mdt:A2.625SeniorNotesDue2025Member 2024-10-17 2024-10-17 0001613103 mdt:A1.125SeniorNotesDue2027Member 2024-10-17 2024-10-17 0001613103 mdt:A0.375SeniorNotesDue2028Member 2024-10-17 2024-10-17 0001613103 mdt:A3.000SeniorNotesDue2028Member 2024-10-17 2024-10-17 0001613103 mdt:A3.650SeniorNotesDue2029Member 2024-10-17 2024-10-17 0001613103 mdt:A1.625SeniorNotesDue2031Member 2024-10-17 2024-10-17 0001613103 mdt:A1.000SeniorNotesDue2031Member 2024-10-17 2024-10-17 0001613103 mdt:A3.125SeniorNotesDue2031Member 2024-10-17 2024-10-17 0001613103 mdt:A0.750SeniorNotesDue2032Member 2024-10-17 2024-10-17 0001613103 mdt:A3.375SeniorNotesDue2034Member 2024-10-17 2024-10-17 0001613103 mdt:A3.875SeniorNotesDue2036Member 2024-10-17 2024-10-17 0001613103 mdt:A2.250SeniorNotesDue2039Member 2024-10-17 2024-10-17 0001613103 mdt:A1.500SeniorNotesDue2039Member 2024-10-17 2024-10-17 0001613103 mdt:A1.375SeniorNotesDue2040Member 2024-10-17 2024-10-17 0001613103 mdt:A4.150SeniorNotesDue2043Member 2024-10-17 2024-10-17 0001613103 mdt:A1.750SeniorNotesDue2049Member 2024-10-17 2024-10-17 0001613103 mdt:A1.625SeniorNotesDue2050Member 2024-10-17 2024-10-17 0001613103 mdt:A4.150SeniorNotesDue2053Member 2024-10-17 2024-10-17 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   _____________________________  FORM 8-K   _____________________________  CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 17, 2024   _____________________________  Medtronic plc (Exact name of Registrant as Specified in its Charter)    _____________________________    Ireland   1-36820   98-1183488 (State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer Identification No.) Building Two Parkmore Business Park West Galway , Ireland (Address of principal executive offices) (Zip Code) + 353 1 438-1700 (Registrant’s telephone number, including area code) Not Applicable Former name or former address, if changed since last report Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursu

View on Read The Filing